A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)
NCT ID: NCT02519088
Last Updated: 2015-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
477 participants
OBSERVATIONAL
2015-08-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy.
The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.
NCT04398238
Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty
NCT02747615
Development of a Predictive Algorithm for a Hemoglobin Value of Less Than 10 g/dl Postoperatively in Scheduled Hip or Knee Arthroplasty
NCT05605860
Effect of Early Administration of TXA in Adult Hip Fractures
NCT05047133
Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs
NCT07309848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* combined surgery, like first extracting a femur nail and than undergoing THA
* any other kind of combined or simultaneous surgery
* any kind of coagulopathy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Krankenhaus der Barmherzigen Brüder Trier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ion-Andrei Popescu, MD
Ion-Andrei Popescu, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ion-Andrei Popescu, MD
Role: PRINCIPAL_INVESTIGATOR
Krankenhaus der Barmherzigen Brüder Trier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Krankenhaus der Barmherzigen Brüder Trier
Trier, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KrankenhausBBT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.